AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2021
Jan 5, 2021
34975_dirs_2021-01-05_0409df37-a43a-4cc5-8999-eec5b3fbffc0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2020-12-31
Reporting Person: Rossi Michael A. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Common Stock | F | 3744 | $4.29 | Disposed | 147276 | Direct |
Footnotes
F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on December 31, 2020.
F2: Includes (a) 47,753 remaining restricted stock units that will vest on July 18, 2021 and 2022; (b) 32,319 remaining restricted stock units that will vest on December 31, 2021, 2022 and 2023; (c) 43,092 restricted stock units with performance based vesting conditions tied to relative total shareholder return that will vest on June 11, 2021, 2022 and 2023; and (d) 24,112 shares of common stock beneficially owned by the Reporting Person.